Product
DE-109
Aliases
DE-109 Intravitreal Injections
1 clinical trial
1 indication
Indication
Non-infectious UveitisClinical trial
LUMINA: A Phase III, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye.Status: Terminated, Estimated PCD: 2022-06-14